Surveillance for stage 1 (overtly non-metastatic) germ cell tumours

被引:0
|
作者
Rustin, GJS [1 ]
机构
[1] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surveillance is a standard form of management in many centres for patients with stage 1 non-seminomatous germ cell tumours of the testis who lack high risk factors. Patients who are reported to have vascular or lymphatic invasion by an experienced pathologist have about 40% chance of relapse and should be considered for adjuvant chemotherapy. Provided a close surveillance programme is adhered to, survival exceeds 98%. A surveillance programme is now also gaining acceptance for stage I ovarian germ cell rumours.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 50 条
  • [1] Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours
    Cullen, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 342 - 348
  • [2] Surveillance in stage I nonseminomatous germ cell tumours of the testis
    Zuniga, Alvaro
    Kakiashvili, David
    Jewett, Michael A. S.
    [J]. BJU INTERNATIONAL, 2009, 104 (9B) : 1351 - 1356
  • [3] Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre?
    Jones, A
    Fergus, JN
    Chapman, J
    Houghton, L
    [J]. BJU INTERNATIONAL, 1999, 84 (01) : 79 - 84
  • [4] Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol
    Honeyball, F.
    Murali-Ganesh, R.
    Hruby, G.
    Grimison, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (10) : 1081 - 1084
  • [5] Metastatic Germ Cell Tumours
    Massard, C.
    Loriot, Y.
    Fizazi, K.
    [J]. ONCOLOGIE, 2014, 16 (04) : 161 - 165
  • [6] COMPLIANCE OF MALES WITH STAGE 1 TESTICULAR GERM CELL TUMOURS (TGCT) ON AN ACTIVE SURVEILLANCE (AS) PROTOCOL
    Honeyball, F.
    Murali-Ganesh, R.
    Hruby, G.
    Grimison, P.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 41 - 41
  • [7] COMPLIANCE OF MALES WITH STAGE 1 TESTICULAR GERM CELL TUMOURS (TGCT) ON AN ACTIVE SURVEILLANCE (AS) PROTOCOL
    Honeyball, F.
    Murali-Ganesh, R.
    Hruby, G.
    Grimison, P.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 34 - 35
  • [8] MANAGEMENT OF NON-METASTATIC DUODENAL NEUROENDOCRINE TUMOURS
    Christou, N.
    Bouv-Hez, M. Mekkan
    Derbey, L.
    de Mestier, L.
    Lorenzo, D.
    Walter, T.
    Perrier, M.
    Cadiot, G.
    Goichot, B.
    Pracht, M.
    Lievre, A.
    Coriat, R.
    Valancot, S.
    Guimbaud, R.
    Carrere, N.
    Bacoeur-Ouzillou, O.
    Belleannee, G.
    Smith, D.
    Laboureau, S.
    Hescot, S.
    Julie, C.
    Teissier-Clement, M.
    Thereaux, J.
    Ferru, A.
    Evrad, C.
    Mathonnet, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2023, 110
  • [9] OUTCOMES OF PROGRESSION ON SURVEILLANCE FOR CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOURS
    Nayan, Madhur
    Jewett, Michael A. S.
    Anson-Cartwright, Lynn
    Bedard, Philippe
    Moore, Malcolm
    Chung, Peter
    Warde, Padraig
    Sweet, Joan
    O'Malley, Martin
    Hamilton, Robert J.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E114 - E115
  • [10] A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours
    Atsü, N
    Eskiçorapçi, S
    Üner, A
    Ekici, S
    Güngen, Y
    Erkan, I
    Uygur, MC
    Özen, H
    [J]. BJU INTERNATIONAL, 2003, 92 (01) : 32 - 35